Combination therapies against cancer targeting CD38 and TGF-β
US-12590167-B2 · Mar 31, 2026 · US
This page is not indexed by search engines while we improve data quality.
Shapiro Gary patents
Shapiro Gary is listed as an inventor on 20 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Shapiro Gary |
| Total patents | 20 |
| First publication | Aug 30, 2018 |
| Latest publication | Mar 31, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Chimeric receptors targeting adgre2 and/or clec12a and uses thereof
US-2025250356-A1 · Aug 7, 2025 · US
Chimeric receptors targeting ADGRE2 and/or CLEC12A and uses thereof
US-12331129-B2 · Jun 17, 2025 · US
Binding proteins and engineered cells specific for neoantigens and uses thereof
US-2025152717-A1 · May 15, 2025 · US
Anti-tgf-beta antibodies and their use
US-2025026821-A1 · Jan 23, 2025 · US
Car-expressing immune cells that specifically target mesothelin and uses thereof
US-2024374721-A1 · Nov 14, 2024 · US
Engineered immune cell that specifically targets mesothelin and uses thereof
US-2024350627-A1 · Oct 24, 2024 · US
Anti-TGF-beta antibodies and their use
US-12049496-B2 · Jul 30, 2024 · US
Cell therapy compositions and methods for modulating tgf-b signaling
US-2024226295-A9 · Jul 11, 2024 · US
Cell therapy compositions and methods for modulating tgf-b signaling
US-2024131158-A1 · Apr 25, 2024 · US
Recent patents
Latest publications not already listed above.
Compositions of guanylyl cyclase c (gcc) antigen binding agents and methods of use thereof
US-2024050473-A1 · Feb 15, 2024 · US
Compositions of guanylyl cyclase c (gcc) antigen binding agents and methods of use thereof
US-2024033359-A1 · Feb 1, 2024 · US
Chimeric antigen receptors targeting cd19 and use thereof
US-2023346938-A1 · Nov 2, 2023 · US
Chimeric receptors targeting adgre2 and/or clec12a and uses thereof
US-2022363775-A1 · Nov 17, 2022 · US
Anti-tgf-beta antibodies and their use
US-2022195026-A1 · Jun 23, 2022 · US
Anti-TGF-beta antibodies and their use
US-11242384-B2 · Feb 8, 2022 · US
Combination therapies against cancer targeting cd38 and tgf-beta
US-2021155708-A1 · May 27, 2021 · US
Anti-tgf-beta antibodies and their use
US-2020399358-A1 · Dec 24, 2020 · US
Anti-TGF-β antibodies and their use
US-10766955-B2 · Sep 8, 2020 · US
Anti-tgf-beta antibodies and their use
US-2018244763-A1 · Aug 30, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Sanofi Sa | 9 |
| Takeda Pharmaceuticals Co | 6 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Millennium Pharm Inc | 4 |
| Sloan Kettering Inst Cancer Res | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 20 |
| A61K2039/505 | 15 |
| C07K2317/565 | 12 |
| C07K2317/92 | 11 |
| C07K2317/76 | 11 |